BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2942495)

  • 1. Protection against non-specific bronchial hyperreactivity and bronchodilating action of procaterol in atopics.
    Dal Negro RW; Zoccatelli O; Pomari C; Turco P; Monici Pretti P
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):323-5. PubMed ID: 2942495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Duration of the therapeutic effect of a beta 2 stimulant (procaterol hydrochloride) in patients with asthmatiform bronchopathies].
    Cammarata A; Mazzarella G; Grella E; Liccardo G
    Arch Monaldi Mal Torace; 1988; 43(2):131-40. PubMed ID: 2908377
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the bronchodilating activity of procaterol and nicardipine in chronic forms of bronchial asthma].
    Ardizzi A; Barberis S; Giorgis GE; Oliaro A; Galietti F; Ciotta D
    Minerva Med; 1987 Oct; 78(19):1433-5. PubMed ID: 2959882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new bronchodilating agent, procaterol, in preventing exercise-induced asthma.
    Ioli F; Donner CF; Fracchia C; Manini G; Patessio A; Spada EL; Vecchio C
    Int J Clin Pharmacol Res; 1986; 6(5):389-96. PubMed ID: 2946644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum bronchodilator effect of pirbuterol and procaterol administered as sprays with and without an aerochamber.
    Solé D; Villalba SR; Sestelo MR; Scalabrin DM; Soares FJ; Naspitz CK
    Rev Paul Med; 1993; 111(3):397-402. PubMed ID: 8108632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study between procaterol and salbutamol in mild to moderate bronchial asthma].
    Legris C; Boulet LP; Lafrance L; Bélanger J; Beaupré A
    Therapie; 1987; 42(2):213-6. PubMed ID: 2956725
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible site of bronchodilation due to inhaled procaterol aerosol in asthmatic patients.
    Taguchi O; Hida W; Nogami H; Inoue H; Takishima T
    Eur J Clin Pharmacol; 1988; 34(5):433-7. PubMed ID: 2974417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New assessment of airway responsiveness. Effect of pretreatment with procaterol on allergen-induced bronchoconstriction.
    Takishima T; Taguchi O; Hida W; Nogami H; Shimizu Y; Inoue H
    Chest; 1989 Sep; 96(3):522-7. PubMed ID: 2527732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reproducibility of the results of bronchial reactivity tests].
    Kandt D
    Z Erkr Atmungsorgane; 1984; 162(1):30-5. PubMed ID: 6719958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and duration of action of procaterol, a new bronchodilator.
    Zanetti CL; Rotman HH; Dresner AJ
    J Clin Pharmacol; 1982; 22(5-6):250-3. PubMed ID: 6213680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of diet on the efficacy onset and duration of action of procaterol hydrochloride tablets.
    Spangler DL; Lutz CN; Tinkelman D
    Ann Allergy; 1987 Jan; 58(1):59-62. PubMed ID: 2948431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of exercise-induced bronchospasm in asthmatic children. Effect of aerosol and oral procaterol hydrochloride.
    Morooka T; Nishima S; Ota S
    J Asthma; 1987; 24(6):335-46. PubMed ID: 2965139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the bronchodilating effects of five beta-adrenergic stimulants administered by inhalation to patients with bronchial asthma].
    Kokubu H
    Arerugi; 1993 Jun; 42(6):699-705. PubMed ID: 8102230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
    Ulmer WT; Scholz HJ; Baines A
    Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New pharmacological aspects of the bronchodilating activity of procaterol.
    Folco GC; Passoni E; Viganò T; Daffonchio L; Rossoni G; Brunelli G; Berti F
    Pharmacol Res Commun; 1983 Nov; 15(10):909-21. PubMed ID: 6242845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic modulation of bronchial hyperreactivity.
    Lowhagen O
    Eur J Respir Dis Suppl; 1982; 117():97-120. PubMed ID: 6807704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of non-specific bronchial hyperreactivity. Dose-dependent effect of sodium cromoglycate metered dose aerosol.
    Del Bufalo D; Fasano L; Patalano F; Ruggieri F; Gunella G
    Allergol Immunopathol (Madr); 1988; 16(2):77-80. PubMed ID: 3134808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilating effect and anabolic effect of inhaled procaterol.
    Ikezono K; Maeda T; Kamata M; Mori T; Yabuuchi Y
    Int J Sports Med; 2008 Nov; 29(11):888-94. PubMed ID: 18461498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. I. Subcutaneous comparison with epinephrine.
    Glass P; Dulfano MJ
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):141-9. PubMed ID: 4144566
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness.
    Strandberg K; Ek A; Palmberg L; Larsson K
    J Intern Med; 2008 Jul; 264(1):83-94. PubMed ID: 18298484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.